News

RiboPro has won the Blue Tulip Award hosted by Accenture in the Netherlands last week. Formerly known as Accenture Innovation Awards, the annual Blue Tulip Awards identifies the most promising […]

Time flies when you are having fun; it is already a bit more than 1 year that Marc Penders joined RiboPro. As Head of Production, he has coordinated the synthesis […]

Do you like to work with messenger RNA, but not sure how to start? Are you wondering about what experimental parameters to keep an eye on? Then we have a […]

Now mRNA has proven its worth as a vaccination agent, more and more researchers are becoming aware of the benefits of mRNA for vaccination, therapy and research purposes. However, a […]

Silvy is a seasoned executive, with extremely valuable experience in scaling a science-driven start-up, and an experienced scientist as well. From the 1st of May on, she will employ those […]

Recently our founder and CEO, Sander van Asbeck, was interviewed by Jan Taco te Gussinklo for ReportersOnline. In this article, they discussed the role of mRNA in the near and […]

On the second of April 2021, RiboPro is officially 1 year old and that is cause for celebration. Especially, since we started during a difficult time, in which lab-access, funding […]

Monday 22 March 2021, Oss, the Netherlands – RiboPro announced it has successfully closed a funding round of €1.2 million, led by Stichting Vlasroot, with a consortium of BOM, Rockstart […]

Today, the 18th of March, we launch our new website. With this website, we will build a center of knowledge on mRNA, readily available to our customers. In addition, we […]